Metropolitan Speech Pathology Cliffside Park, NJ - 07010

Metropolitan Speech Pathology is categorized under Pathological Laboratories in Cliffside Park, NJ and active since 2005.

Metropolitan Speech Pathology was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.

If you are seeking more information, feel free to contact Tom Burke at the company’s single location by writing to 19 Cortland Place, Cliffside Park, New Jersey NJ 07010 or by phoning (201) 943-1931. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Metropolitan Speech Pathology
Contact Person: Tom Burke
Address: 19 Cortland Place, Cliffside Park, New Jersey 07010
Phone Number: (201) 943-1931
Annual Revenue (USD): $100.000 to $499.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Pathological Laboratories
SIC Code: 8071
NAICS Code: 621511
Share This Business:

Metropolitan Speech Pathology was started in 2005 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Tom Burke for inquiries that concern Metropolitan Speech Pathology by calling the company number (201) 943-1931, as your correspondence is most welcome. Additionally, the physical location of the single location of Metropolitan Speech Pathology can be found at the coordinates as well as the street address 19 Cortland Place in Cliffside Park, New Jersey 07010.

For its online presence, you may visit Metropolitan Speech Pathology’s website at and engage with its social media outlets through on Twitter and on Facebook.